banner
    Home
    Registration
    Accommodation
    Webcasting
    Contact
     Home
     Welcome Note
     Our Vision
     Committees
     Industry Advisory Board (IAB)
     Scientific Programme
         Satellite Symposia
     Timetable
     CME
         CME Certificate
     Abstract Submission
         Poster Presentations
         Poster Presentation Guidelines
         Best Abstracts Competition
     Registration
         Accompanying Persons Program
         Invitation Letter
     Accommodation
         Hilton Prague Hotel
         Hilton Prague Old Town Hotel
         Corinthia Hotel Prague
         Clarion Congress Hotel
         Panorama Hotel Prague
     Sponsors
     Sponsorship & Exhibition
         Sponsorship Categories
     General Information
         Before you travel...
     About Prague
         Transportation
         Hints and Tips
     CODHy 2006
     CODHy 2008
     CODHy 2008 Webcasting
     CODHy 2008 Abstract Winners
     CODHy 2010 Webcasting
     CODHy Latin America
     CODHy Asia Pacific
     Partners
     Contact Us
The 3rd World Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Hilton Hotel, Prague, Czech Republic, May 13-16, 2010
 
  Friday, May 14, 2010 Print

HALL A

08:15-10:00
 
08:15-08:30
Plenary Session 1
OUTCOME STUDIES IN THE TREATMENT OF TYPE 2 DIABETES (T2D)
Chairpersons: S. Del Prato, Italy I. Raz, Israel
08:30-09:00
 
 
09:00-09:20
 
 
09:20-09:40
 
09:40-10:00
Diabetes and Cancer
S. Del Prato, Italy       
Implications of the new regulatory guidelines: Cardiovascular outcome studies as an integral part of the development process of novel anti diabetic drugs
B. Hirshberg, Israel
What can be learnt from the new ACCORD sub-analysis?
H. Ginsberg, USA
Act now
R.A. DeFronzo, USA
 
        
 
10:30-12:30
 
10:30-10:35
Session 2
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: A CLINICAL COMPARISON
Chairperson: J.J. Holst, Denmark
10:35-11:05
10:35-10:50
10:50-11:05
11:05-11:20
 
11:20-12:00
11:20:11:40
11:40-12:00
12:00-12:30
Impact of glycaemic control impact on body weight potential to reduce cardiovascular (CV) risk
GLP-1: G. Sesti, Italy
DPP-4: D. Dicker, Israel 
AUDIENCE DISCUSSION 
 
Beta-cell protection
Animal studies: M. Donath, Switzerland
Human perspective:  A.J. Garber, USA
PANEL DISCUSSION 
D. Dicker, Israel M. Donath, Switzerland A.J. Garber, USA G. Sesti, Italy
 
            
13:30-14:15
GUIDED POSTER TOUR#1
Poster Presentation Area


13:30-14:15
Session 5
NORMALIZING A1C – EFFICACY AND SAFETY OF NEW NOVEL DRUGS
R.A. DeFronzo, USA


 
14:15-16:00
14:15-14:20
Session 6 
THERAPY IN THE EARLY STAGE
Chairperson: A. Ametov, Russia  J. Meigs, USA
14:20-14:50
14:20-14:35
14:35-14:50
14:50-15:05
 
15:05-15:35
15:05-15:20
15:20-15:35
15:35-16:00
 
Pharmacologic prevention of T2DM
Pro: R.A. DeFronzo, USA
Con: J. Tuomilehto, Finland
AUDIENCE DISCUSSION

Metformin failure: What is next?
Incretins: S. Del Prato, Italy 
Others: I. Raz, Israel
PANEL DISCUSSION 
R.A. DeFronzo, USA S. Del Prato, Italy  I. Raz, Israel  J. Tuomilehto, Finland
   
           

16:30-18:30
Session 9
T2D IN CHILDHOOD
Chairpersons: R. Bonadonna, Italy S. Cernea, Romania
16:35-16:55
 
16:55-17:15
  
17:15-17:35
   
17:35-17:55
  
17:55-18:30
 
Epidemiology and pathophysiology
S. Caprio, USA 
Metabolic syndrome in pediatrics
R. Weiss, Israel
The accelerator hypothesis and the double diabetes
P. Pozzilli, Italy       
Treatment of T2D in youth: What's on the horizon?
S. Arslanian, USA  
PANEL DISCUSSION 
S. Arslanian, USA S. Caprio, USA P. Pozzilli, Italy R. Weiss, Israel    
 

HALL B

10:30-12:30
 
10:30-10:35
Session 3
OPTIMAL BLOOD PRESSURE CONTROL
Chairperson: G. Mancia, Italy Y. Yodfat, Israel
10:35-11:05
10:35-10:50
10:50-11:05
11:05-11:20
 
11:20-12:00
11:20-11:40
11:40-12:00
12:00-12:30
The blood pressure legacy
Pro:  L.M. Ruilope, Spain    
Con: G. Parati, Italy  
AUDIENCE DISCUSSION 
   
Blood pressure: The lower, the better
Pro: G. Mancia, Italy    
Con: E. Grossman, Israel       
PANEL DISCUSSION  
G. Mancia, Italy G. Parati, Italy L. Ruilope, Spain E. Grossman, Israel
   
13:30-14:15
GUIDED POSTER TOUR#1
Poster Presentation Area


 
14:15-16:00
14:15-14:20
Session 7
HYPERTENSION TREATMENT
Chairperson: E. Grossman, Israel 
14:20-14:45
 
14:45-15:15
14:45-15:00
15:00-15:15
15:15-16:00
Are the benefits of RAS blockage beyond BP lowering in CV prevention?
Y. Yodfat, Israel       
Diuretic treatment of hypertension
Pro: E. Grossman, Israel    
Con: P. Verdecchia, Italy     
PANEL DISCUSSION
E. Grossman, Israel P. Verdecchia, Italy Y. Yodfat, Israel        
  
 

16:30-18:30
Session 10
RENIN-ANGIOTENSIN SYSTEM (RAS) AND COMPLICATIONS
Chairperson: L.M. Ruilope, Spain
16:35-17:05
16:35-16:50
16:50-17:05
17:05-17:20

17:20-17:50
17:20-17:35
17:35-17:50
17:50-18:30
Estimated glomerular filtration rate (eGFR) or albuminuria as predictors for renal and CV outcome
eGFR: M. Ravid, Israel
Albuminuria: D. de Zeeuw, Netherlands
AUDIENCE DISCUSSION  
    
RAS blockade for every diabetic
Pro: L.M. Ruilope, Spain  
Con: A. Solini, Italy  
PANEL DISCUSSION   
D. de Zeeuw, Netherlands M. Ravid, Israel L.M. Ruilope, Spain A. Solini, Italy   
                    

HALL C


10:30-12:30
10:30-10:35
Session 4
OBESITY: CAUSE AND DIFFERENT APPROACHES
Chairperson: E. Ravussin, USA
10:35-10:55
  
10:55-11:15
  
11:15-11:35
  
11:35-11:55
 
11:55-12:30
Should obesity be treated at any age?
R. Bonadonna, Italy            
Physical exercise. How and how much?
P. De Feo, Italy  
Effective diet for weight loss
I. Shai, Israel
Caloric restriction Vs bariatric surgery
E. Ravussin, USA
PANEL DISCUSSION
R. Bonadonna, Italy P. De Feo, Italy  E. Ravussin, USA I. Shai, Israel
     
13:30-14:15
GUIDED POSTER TOUR#1
Poster Presentation Area



14:15-16:00
14:15-14:20
Session 8
GLUCOSE VARIABILITY
Chairpersons: R. Niecestro, USA M. Petkova, Bulgaria 
14:20-14:50
14:20-14:35
14:35-14:50
14:50-15:05
  
15:05-15:35
15:05-15:20
15:20-15:35
15:35-16:00
Postprandial glucose and glucose variability. Should we care?
Pro: A. Ceriello, UK     
Con: E. Standl, Germany   
AUDIENCE DISCUSSION 
    
Continuous glucose monitoring (closing the loop)
Expectations: M. Phillip, Israel  
Doubts: J.H. DeVries, Netherlands
PANEL DISCUSSION
A. Ceriello, UK  J.H. DeVries, Netherlands M. Philip, Israel  E. Standl, Germany 
                        
 
16:30-18:30
16:30-16:35
Session 11
BLOOD VESSELS, ENDOTHELIUM AND METABOLIC DISEASES
Chairperson: C.D.A. Stehouwer, Netherlands
16:35-16:55
 
16:55-17:15
  
17:15-17:35
    
17:35-17:55 
 
17:55-18:30
Inflammation and innate immunity
J.M. Fernández-Real, Spain
The role of metalloproteinases. At the interface between metabolic and inflammatory disorders
M. Federici, Italy   
Vascular disease in diabetes. The role of reparatory mechanisms
A. Avogaro, Italy
Endothelial factors and diabetic nephropathy
L. Gnudi, UK 
PANEL DISCUSSION
A. Avogaro, Italy M. Federici, Italy  J.M. Fernández-Real, Spain L. Gnudi, UK 

Home   
Copyright © 2007 Comtecmed.com. All rights reserved.   The website was last updated on 07/31/2011 Created by    WebStudio.co.il